You are here
Carlyle raises US$6.55b for new Asia fund
CARLYLE Group said on Thursday that it had raised US$6.55 billion for its Asia private equity fund, its biggest ever, which will seek buyout and strategic investment opportunities across a wide range of sectors in the region.
The latest fund is more than Carlyle's initial target of US$5 billion and 65 per cent bigger than its previous Asia buyout fund, said the US-based private equity firm with US$201 billion of assets under management globally.
Reuters reported last month, citing people with knowledge of the matter, that Carlyle had raised its Asia fund-raising target following a strong response from its investors and that it was looking to close the fund at US$6.5 billion.
X D Yang, chairman of Carlyle Asia excluding Japan, said in a statement: "We expect to see more and larger investment opportunities in the region driven by innovation, attractive demographics, rising consumption and corporate spin-offs."
Investor interest in Asia-focused private equity has grown as deals have increased in size following corporate restructuring and as global private equity funds make headway in key markets, including China, India and Japan.
Carlyle, together with more than a dozen investors including Singaporean sovereign wealth fund GIC Pte Ltd and state investor Temasek Holdings (Private) Ltd, as well as US private equity firm Warburg Pincus LLC, joined Ant Financial Services Group's latest US$14 billion fund-raising, the world's largest ever.
The Asian region has become a key battleground for global financial sponsors - 342 funds raised a combined US$107 billion in Asia last year, said data provider Preqin.
US-based KKR & Co closed a new Asia-focused buyout fund in June last year after raising US$9.3 billion, a record for the region. The record could soon be broken by Chinese investment firm Hillhouse Capital Group, which has received commitments of over US$10 billion in a new private equity fund, according to people familiar with the fund-raising.
Carlyle is also in the process of raising a Chinese yuan fund of four billion (S$856.4 million), which would target opportunities in the world's second-largest economy, a person with direct knowledge told Reuters last month.
The Washington, DC-based firm's existing portfolio firms in Asia range from a stake in Chinese Internet giant Tencent's e-book unit China Literature to Metropolis Healthcare, an India-based global operator of pathology laboratories.
The investments generated an 18 per cent net internal rate of return in its last US$3.9 billion Asia fund by the end of March, according to its first-quarter earnings report. REUTERS